[Pyridimocarbamate (prodectin)-induced acute liver damage, cirrhosis and primary liver cancer--accidental finding?].
Authors have verified during the postmortem of a 60-year-old woman, in addition to clinically manifested vascularly and parenchymally decompensated cirrhosis a small hepatocellular carcinoma with signs of vascularization. The patient received since four years pyridinolcarbamate (Prodectin) because of obliterating peripheral arteriosclerosis. During treatment, icterus occurred the drug-induced nature of which was proved by the provocation-test. Owing to the known hepatotoxic effect of pyridinolcarbamate the question must be raised concerning a possible causal relationship between the acute hepatic damage having occurred four years ago and the cirrhosis and cancer observed in the autopsy material. The reporting of this case was aimed at drawing attention to such a possibility.
Kendrey
G
G
Kiss
F
F
László
B
B
D000208:Acute Disease; D001161:Arteriosclerosis / Q000188:drug therapy; D002219:Carbamates / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000009:adverse effects* / Q000627:therapeutic use
D002219:Carbamates; D011727:Pyridinolcarbamate
Pyridinolcarbamat (Prodectin) okozta heveny májkárosodás, cirrhosis és primaer májrák. Véletlen lelet?